African Science.
Global Impact.
GreenHelix Biotech Ltd is a Nigerian-founded biotechnology company pioneering plant-based molecular approaches to vaccine development — addressing critical gaps in immunization access across Africa and the developing world.
Mission & Vision
Mission
To develop and deliver safe, effective, and affordable plant-derived vaccines that eliminate barriers of cost, logistics, and infrastructure — ensuring universal access to immunization.
Vision
A world where every child, regardless of where they are born, has access to the vaccines they need to live a healthy and productive life.
What We Stand For
Scientific Integrity
Rigorous methodology, transparent reporting, and evidence-based decision-making at every stage of research and development.
Equity-Centered Innovation
Every technology decision is evaluated through the lens of accessibility and affordability for underserved populations.
Sustainability
Plant-based bioprocessing aligns science with ecological responsibility — fewer carbon emissions, renewable inputs, biodegradable byproducts.
African-Led Excellence
We are proudly African in origin and global in ambition — proving that world-class biotech innovation can emerge from our continent.
The Team Behind the Science
Ethics & Research Integrity
Our commitment to ethical scientific conduct
GreenHelix adheres to the highest international standards of research ethics, biosafety, and scientific transparency. All research activities are conducted in compliance with relevant institutional, national, and international regulatory guidelines. We are committed to open science, responsible disclosure, and community engagement in all research involving public health applications.